Novartis Drug Data Allegations Revive Questions Over Ethics
Signage is displayed in front of the Novartis AG Institutes for BioMedical Research building in Cambridge, Massachusetts, U.S. (Photographer: Scott Eisen/Bloomberg)

Novartis Drug Data Allegations Revive Questions Over Ethics

(Bloomberg) -- Concern over Novartis AG’s corporate culture returned to the spotlight after U.S. regulators said the Swiss drugmaker delayed disclosing manipulation of animal testing data for the w...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.